Showing results (121-130 of 154) with videos related to
Sort By:
Pageof 16
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 1, 1994
Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopauseD Thiébaud, P Burckhardt, J Melchior, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 18, 2003
Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal womenN Pugnale, V Giusti, M Suter, et al.Schweizerische Medizinische Wochenschrift|January 3, 1976
[Destructive arthropathies associated with articular chondrocalcinosis. Clinical and metabolic study of 16 cases]A Cosendai, J C Gerster, T L Vischer, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Treatment of bone metastases from breast cancer and myeloma with pamidronateD Thiébaud, S Leyvraz, V von Fliedner, et al.Journal of the National Cancer Institute|May 20, 1992
Pharmacokinetics of pamidronate in patients with bone metastasesS Leyvraz, U Hess, G Flesch, et al.Clinical Rheumatology|September 1, 1986
Calcitonin and reflex sympathetic dystrophy syndromeC Gobelet, J L Meier, W Schaffner, et al.Calcified Tissue International|November 1, 1987
The effect of rectal and nasal administration of salmon calcitonin in normal subjectsT Buclin, J P Randin, A F Jacquet, et al.Climacteric : the Journal of the International Menopause Society|March 23, 2002
A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tiboloneD Thiébaud, J M Bigler, S Renteria, et al.The American Journal of Medicine|November 14, 1997
Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosisD Thiébaud, P Burckhardt, H Kriegbaum, et al.European Journal of Clinical Investigation|July 1, 1996
Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantationD Thiébaud, M A Krieg, D Gillard-Berguer, et al.Pageof 16